Novel Chemo Device for Early Bladder Cancer Wins FDA Approval

(MedPage Today) — The FDA approved a gemcitabine intravesical system (Inlexzo) for adults with non-muscle-invasive bladder cancer (NMIBC), the agency announced on Tuesday.
The indication for the nucleoside metabolic inhibitor chemotherapy-containing…